Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: New PR on share buyback

Sep 27, 2007 03:18PM

To date we’ve acquired more than 18 million of our own shares under a program that began back in July of 2006 when the management and the Board of Directors felt that our stock was undervalued in the market and that this would be a prudent use of corporate funds. We’ve suspended share repurchases for a while because I no longer believe this is the best use of the company’s cash at this time. Although we still believe our shares are undervalued, I strongly believe we can put that money to better and more profitable use elsewhere.

Common stock held in treasury, at cost - 13,467,527 shares at May 31, 2007.

Looks like approximately 5,000,000 purchased since May 31, 2007.

Be well


Sep 27, 2007 05:17PM
1
Sep 27, 2007 05:46PM
1
Sep 27, 2007 05:53PM
1
Sep 27, 2007 05:58PM
10
Sep 27, 2007 06:10PM

Sep 27, 2007 06:21PM
3
Sep 27, 2007 06:37PM
2
Sep 27, 2007 06:39PM
3
Sep 27, 2007 07:03PM
3
Sep 27, 2007 07:29PM
2
Sep 27, 2007 09:01PM
1
Sep 28, 2007 08:07AM
Share
New Message
Please login to post a reply